Form 4 for AGX ARGAN INC
Accepted 2022-04-19 00:00:00 ET · period of report 2022-04-16 · accession 0001415889-22-004132 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-19 | 2022-04-16 | AGX | Deily Richard H | VP | M - OptEx | $0.00 | +1,193 | 2,193 | +119% | $0 |
| DM | 2022-04-19 | 2022-04-18 | AGX | Deily Richard H | VP | A - Grant | $0.00 | +7,000 | 57.0K | +14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-16 | M | A | 1,193 | $0.00 | 2,193 | D | — | — | (F1) On April 16, 2022, the Reporting Person had Time-Based Restricted Stock Units (the "TRSUs") vest in the amount of 1,193 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 3,500 TRSU award that was granted on April 16, 2022 and is adjusted for cash dividends. |
| 2 | Derivative | Time-Based Restricted Stock Units | 2022-04-18 | A | A | 3,500 | $0.00 | 5,834 | D | $0.00 · — to — | 3,500 Common Stock | (F6) As of the date of this filing, the remaining number of TBRSUs beneficially owned by the Reporting Person includes (a) 2,334 shares of TBRSUs granted on April 12, 2021; and (b) 3,500 shares of TBRSUs granted on April 18, 2022, all to vest pursuant to the three year vesting schedule reported under footnote 5 above. (F5) On April 18, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 3,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/18/2023. |
| 3 | Derivative | Option to Purchase Common Stock | 2022-04-18 | A | A | 3,500 | $0.00 | 57,000 | D | $36.78 · 2023-04-18 to 2032-04-18 | 3,500 Common Stock | (F2) On April 18, 2022, the Reporting Person received 10-year options to purchase 3,500 shares of the Issuer's common stock with an exercise price of $36.78 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/18/2023. (F4) (e) options to acquire 10,000 shares of common stock at a price of $33.81 per share with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030; (f) options to acquire 3,500 shares of common stock at a price of $54.60 per share with a Date Exercisable of 4/16/2022 and Expiration Date of 4/16/2031, and (g) options to acquire 3,500 shares of common stock at a price of $36.78 per share with a Date Exercisable of 4/18/2023 and Expiration Date of 4/18/2032. Options identified in subjects (c), (d), (e), (f) and (g) are subject to the aforementioned three-year ratably vesting schedule. (F3) As of the date of this Filing, the total number of options owned by the Reporting Person includes (a) options to purchase a total of 10,000 shares of common stock at the price of $33.85 per share with the date exercisable of 04/13/2017 and expiration date of 04/13/2026; (b) options to acquire 10,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 10,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 10,000 shares of common stock at a price of $50.30 per share with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029; |